Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 128, Issue 3, 2004, Pages 432-435

  Lim, Eric ^a   Cornelissen, Jacqueline ^a   Routledge, Tom ^a   Kirtland, Stephen ^a   Charman, Susan C ^b   Bellm, Sarah ^a   Munday, Helen ^a   Khan, Omar ^a   Masood, Imran ^a   Large, Stephen ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

16; 17; 23

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL; COLLAGEN; FLUINDOSTATIN; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TIME SERIES ANALYSIS; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; ASPIRIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; TICLOPIDINE;

EID: 4444244344     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.03.007     Document Type: Article

References (9)

1. Lim E., Ali Z., Ali A., Routledge T., Edmonds L., Altman D.G., et al. Indirect comparison meta-analysis of aspirin therapy after coronary surgery. BMJ. 327:2003;1309
2. Zimmermann N., Kienzle P., Weber A.A., Winter J., Gams E., Schror K., et al. Aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 121:2001;982-984
3. Bhatt D.L., Chew D.P., Hirsch A.T., Ringleb P.A., Hacke W., Topol E.J. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation. 103:2001;363-368
4. Born G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 164:1962;927-929
5. Savcic M., Hauert J., Bachmann F., Wyld P.J., Geudelin B., Cariou R. Clopidogrel loading dose regimens kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost. 25:(Suppl 2):1999;15-19
6. Lau W.C., Waskell L.A., Watkins P.B., Neer C.J., Horowitz K., Hopp A.S., et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation a new drug-drug interaction. Circulation. 107:2003;32-37
7. Mangano D.T. Aspirin and mortality from coronary bypass surgery. N Engl J Med. 347:2002;1309-1317
8. Goldman S., Copeland J., Moritz T., Henderson W., Zadina K., Ovitt T., et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Circulation. 80:1989;1190-1197
9. David J.L., Limet R. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients. Thromb Haemost. 82:1999;1417-1421